| CRISPR Medicine | This is an overview of articles on delivery
Sign-up to weekly Newsletter here.
For the inaugural episode of CMN Live on 26th January 2024, we spoke with Eric Kmiec, Ph.D. about the successes of therapeutic gene editing to date,...
Gene-editing systems, especially CRISPR-Cas9, have revolutionised genome editing, offering potential cures for genetic disorders, cancers, and other...
AAV trailblazer Nicole Paulk, formerly of UCSF, speaks about the latest developments in AAV-based gene therapies and her new company, Siren...
In a recent study, researchers in Denmark engineered lentiviruses to incorporate Cas9 protein fused to viral proteins to allow packaging of Cas9 into...
Webinar
Read more about the webinar - A Novel Non-viral Cargo Delivery Platform: The First in a New Class
Irish-Indian company CyGenica is on a mission to solve the huge challenge surrounding targeted intracellular delivery of gene-editing and other...
At a length of around 100 nucleotides, single guide RNAs are not synthesised efficiently. However, thanks to click chemistry, they can now be...
Extended survival times and inhibited growth of patient-derived glioblastoma brain tumours have been achieved in mice with CRISPR-Cas9 mediated...